2024-520229-35-00
尚未招募
1 期
A clinical study of MK-5661 in healthy people (MK-5661-007)
概览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 16
- 试验地点
- 1
概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Jonathan Kurz
Scientific
Merck Sharp & Dohme LLC
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A study of the effects of single doses of MK-1167 on neurotransmitter cycling in the brain of healthy adult participants using 13C-Magnetic Resonance Spectroscopy.10012272Alzheimer's DementiaNL-OMON51348Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc.48
未知
3 期
K-115 clinical pharmacology studyJPRN-jRCT2080221879Kowa Co., Ltd.30
招募中
不适用
A Phase 1 Study of MK-5890 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid TumorsNL-OMON52475Merck Sharp & Dohme (MSD)51
终止
2 期
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)NCT06161116Merck Sharp & Dohme LLC149
尚未招募
3 期
Phase 3 study of MK-5684 versus alternative NHA in mCRPC Acronym: MK-5684-003D075 ProstateProstateD075PER-048-23Merck Sharp & Dohme LLC., (una subsidiaria de Merck & Co. Inc.)